Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
21%
upside
5 price targets
|
0
%
|
|
|
|
21%
upside
5 price targets
|
0
%
|
|
|
|
21%
upside
3 price targets
|
0
%
|
|
|
229
Kiniksa Pharmaceuticals
KNSA
$3.11B
|
21%
upside
3 price targets
|
0
%
|
|
|
21%
upside
3 price targets
|
0
%
|
|
|
|
21%
upside
7 price targets
|
0
%
|
|
|
|
21%
upside
4 price targets
|
0
%
|
|
|
|
21%
upside
3 price targets
|
0
%
|
|
|
|
21%
upside
3 price targets
|
0
%
|
|
|
|
21%
upside
10 price targets
|
0
%
|
|
|
236
Post Holdings
POST
$5.15B
|
21%
upside
5 price targets
|
0
%
|
|
|
21%
upside
4 price targets
|
0
%
|
|
|
|
20%
upside
3 price targets
|
0
%
|
|
|
|
20%
upside
11 price targets
|
0
%
|
|
|
|
20%
upside
9 price targets
|
0
%
|
|
|
|
20%
upside
9 price targets
|
0
%
|
|
|
|
20%
upside
4 price targets
|
0
%
|
|
|
|
20%
upside
4 price targets
|
0
%
|
|
|
|
20%
upside
5 price targets
|
0
%
|
|
|
|
20%
upside
6 price targets
|
0
%
|
|
|
|
20%
upside
6 price targets
|
0
%
|
|
|
|
20%
upside
8 price targets
|
0
%
|
|
|
|
20%
upside
4 price targets
|
0
%
|
|
|
|
20%
upside
5 price targets
|
0
%
|
|
|
|
20%
upside
3 price targets
|
0
%
|
|